XI’AN, CHINA--(MARKET WIRE)--Jun 29, 2007 -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC BB:HFGB.OB - News), a rapidly growing Chinese company which produces raw materials for pharmaceutical and nutraceutical production, participated in the CPhI Shanghai 2007 Expo from June 19th to June 21st. At the Expo, Huifeng signed five letters of intent for distribution sales contracts valued at approximately $650,000. Three of the contracts are for overseas distribution of the Company’s products totaling $480,000 for Rutin, Quercetin and Diosmin, and two domestically for $170,000 for Troxerutin and L-Rhamnose.
